Clinical trial
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced…
NCT00046176 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00046176 |
|---|---|
| Title | A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients |
| Official title | A Phase III, 48-Week, Open-Label, Randomized, Multicenter Study of the Safety and Efficacy of the Abacavir/Lamivudine Fixed-Dose Combination Tablet Administered QD Versus Abacavir + Lamivudine Administered BID in Combination With a PI or NNRTI in Antiretroviral Experienced Patients. |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | abacavir/lamivudine, abacavir, lamivudine |
| Enrollment | 240 |
| Start date | Aug 26, 2002 |
| Primary completion | May 17, 2004 |
| Completion | May 17, 2004 |
| First posted | Sep 23, 2002 |
| Last update posted | Mar 24, 2020 |
| Countries | Costa Rica, Panama, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: